113¦~10¤ë¸¹ ¹D ªk ªk °T (390)

DEEP & FAR

 

 

±M§Q»¡©ú®Ñ¹ï¥ý«e§Þ³Nªº§åµû³Q¥Î¨Ó¥H

¦³§Q©ó±M§QÅv¤Hªº¤è¦¡¸ÑÄÀ½Ð¨D¶µ

(In re Abbott Diabetes Care Inc.,¬ü°êÁp¨¹¨µ°j ¤W¶Dªk°|2012¦~9¤ë28¤é°µ¥X¨M©w)

                                  

 

§d¨Ø¬Â ±M§Q¤G²Õ¥D¥ô

¡D¥xÆW¤j¾Ç¹AÃÀ¨t¾Ç¤h

¡D¥xÆW¤j¾Ç¹AÃÀ©ÒºÓ¤h

 

¤p±µ¦¬¾¹¤Î

Åã¥Ü³æ¤¸

 

·P´ú¾¹±±¨î³æ¤¸

 

¤j±µ¦¬¾¹

    ¤Î

Åã¥Ü³æ¤¸

 

·P´ú¾¹

 

¹Ï2

 

¹Ï1

 

 

Abbott¾Ö¦³¬ü°ê±M§Q¸¹6,175,752 ¤Î6,565,509¡A¨ä´y­z¤F¥Î©óºÊ´ú¿}§¿¯f±wªÌªº¦å¿}¦ì·Çªº¤èªk¤Î¸Ë¸m¡B¨Ã½Ð¨D¨ã¦³¡u¹q¤Æ¾Ç·P´ú¾¹¡vªº·P´ú¾¹±±¨î³æ¤¸©Î·P´ú¾¹²Õ¥ó¡C¦pAbbottªº±M§Qªº¹Ï1¤Î¹Ï2©Ò¥Ü¡A¹q¤Æ¾Ç·P´ú¾¹42¨Ï¥Î¾É¹q¸ñ½u52¤Î±µÄ²¹Ô49±N°T¸¹¶Ç°e¨ì·P´ú¾¹44¡C±M§Q»¡©ú®Ñ§åµû²{¦³¸Ë¸m¡G(1)Åé¿nÃe¤j¥B¦b¨Ï¥Î®É¤£¤¹³\¦Û¥Ñ¬¡°Ê¡A¥H¤Î(2)¥]¬A¥Î©ó³s±µ¦U­Ó¤¸¥óªº¥~³¡¹qÆl¤Î¹q½u¡A¾É­P¥Î¤á¬¡°Ê¤Î¤é±`¥Í¬¡¨ü¨ì­­¨î¡C

U.S. PTO­ã¤©¹ïAbbotªº±M§Q¶i¦æ¦A¼fªº½Ð¨D¡C¦b¦A¼f¹Lµ{¤¤¡A¼f¬d­û°ò©ó¦h­Ó¤ÞÃÒ¤å¥óªºµ²¦X³Ì²×»é¦^¤F©Ò¦³¸g¨ü¦A¼fªº±M§Q½Ð¨D¶µ¡C¥H¤UÅã¥Üªº¬O¨ä¤¤¤@¥÷¤ÞÃÒ¤å¥óªº¹Ï1¤Î¹Ï3¡C¥ý«e§Þ³Nªº¸Ë¸mÅã¥Ü¥X¨ã¦³¦å¿}°»´ú¾¹1ªº¿ö§Î¶Ç¿é²Õ¥ó2¡A¦å¿}°»´ú¾¹1¨ã¦³¥Î©ó´ú¶q¦å¿}ªº¹q·¥13¡C¥Ñ¹q·¥13±µ¦¬¨ìªº°T¸¹¸g¥Ñµ´½t½u43¡B44¡B¸g¥Ñ¾ÉºÞ45õX°e¨ì¤â¿ö§Î¶Ç¿é²Õ¥ó2¡C

~«ÝÄò~